CDx Diagnostics
Suffern
About CDx Diagnostics
CDx develops and provides diagnostic systems intended to prevent cancer by detecting pre-cancerous cells. It offers OralCDx, an accurate and non-invasive biopsy to evaluate common oral lesions to rule out dysplasia or cancer, prevention of cancer of the oral cavity, pharynx, larynx, and esophagus through early detection of their easily treatable and pre-cancerous precursors. It provides these tests and systems nationally to gastroenterologists, otolaryngologists, oral surgeons, periodontists, and dentists.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $11.0M
- Last round: Series Unknown (Dec 2019)
- Website: cdxdiagnostics.com
- Phone: 845-777-7000
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical, Product Design
Social Profiles
Canonical: https://fsome.com/organization/cdx-diagnostics-106475 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.